HydroSKIN

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of HydroSKIN

What is HydroSKIN?

Property Description
Active ingredient Hydrocortisone
Form Topical preparation (Cream or Ointment)
Pharmacological class Corticosteroid (Glucocorticoid)
Common purpose Symptomatic relief of skin inflammation and itching
Origin Synthetic derivative

Defining HydroSKIN: A Topical Corticosteroid

HydroSKIN is a specialized topical preparation that contains the active ingredient Hydrocortisone, and is classified pharmacologically as a corticosteroid. This medicine is designed for external application to the skin, positioning it within the class of externally applied anti-inflammatory agents. The core substance, Hydrocortisone, is a synthetic glucocorticoid derivative, meaning it is manufactured to mimic the action of the body's natural hormone, cortisol. As a low-potency corticosteroid, HydroSKIN is often recognized as a foundational option for localized inflammatory skin issues, differentiating it from stronger topical agents reserved for more severe conditions.


Composition, Formulation, and General Purpose

The formulation of HydroSKIN is a single-agent product where the Hydrocortisone is suspended within an emulsifying base, such as a cream or ointment, for topical administration. This specific formulation is intended for providing effective symptomatic relief without the potential for extensive systemic absorption typically associated with high-potency formulations. The overarching therapeutic purpose of this medicine is to diminish the localized symptoms of skin inflammation, such as redness and swelling. The product provides anti-inflammatory and antipruritic relief via local action on the skin. This confirms that the medicine's primary benefit is easing discomfort by halting the inflammatory cycle and relieving intense pruritus (itching).


How Does Hydrocortisone Act in the Skin?

The mechanism by which Hydrocortisone provides relief is through its potent anti-inflammatory action achieved via glucocorticoid receptor agonist activity at the site of application. This action locally suppresses the body's overactive inflammatory signaling, inhibiting the function and release of chemical mediators, such as cytokines, that drive inflammation and edema. The resulting decrease in inflammatory signaling delivers a strong antipruritic effect to alleviate chronic or acute itching, anchoring its established role as an effective anti-inflammatory agent for the skin.

What side effects are possible with HydroSKIN?

Possible Side Effects and Safety Information

The safety profile for HydroSKIN (topical hydrocortisone) is officially documented by regulatory authorities, with adverse reactions generally falling into two main categories: local skin effects and potential systemic effects from absorption.

Documented Adverse Reactions

The most common documented adverse reactions are local application site reactions, including burning, pruritus (itching), and irritation.

Less common or rare reactions, typically associated with long-term exposure, fall under Skin and Subcutaneous Tissue Disorders and include skin atrophy (thinning), striae (stretch marks), and telangiectasia (spider veins). Other local effects such as folliculitis and hypo-pigmentation have been reported with a frequency classified as not known.

Systemic Safety Considerations

Adverse reactions classified under Endocrine Disorders relate to the potential for systemic absorption. The most clinically significant potential risks, especially with extensive or prolonged use, include Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and, rarely, features of Cushing's syndrome.

Regulatory safety documents specify that pediatric patients are considered a population with higher susceptibility to these systemic effects due to their body weight-to-skin surface area ratio. The risks of systemic absorption and serious local effects, such as atrophy, are officially documented to increase when the medicine is applied to large surface areas or used under an occlusive dressing.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents for topical hydrocortisone, the active ingredient in HydroSKIN, define the overdose profile primarily through the risk of systemic absorption. This can occur when the product is applied to large surface areas, used for prolonged periods, or utilized under occlusive dressings, allowing the corticosteroid to enter the body's circulation.

When absorption is excessive, the clinical picture is characterized by systemic corticosteroid effects. Documented manifestations include Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and the development of clinical signs associated with Cushing's syndrome, such as hyperglycemia (high blood sugar) and glucosuria (glucose in the urine). Regulatory guidance states that patients with suspected HPA axis suppression may require periodic evaluation using specific tests, such as the ACTH stimulation test or the urinary free cortisol test, to assess recovery.

Immediate Medical Attention:

Urgent medical assistance is required if the product is swallowed. Regulatory instructions mandate that in this event, an individual must seek medical help or immediately contact a Poison Control Center. Immediate attention is also warranted if signs of HPA axis suppression are suspected.

Special Populations:

Official labeling emphasizes that pediatric patients are at greater risk for systemic toxicity due to a higher skin surface area to body weight ratio. Specific signs of toxicity in children can include linear growth retardation, delayed weight gain, and neurological manifestations such as intracranial hypertension and bulging fontanelles.

Therapeutic Uses of HydroSKIN

What HydroSKIN Treats: Main Uses and Benefits

HydroSKIN (topical low-potency hydrocortisone) is a supportive therapeutic agent used across domains where short-term symptomatic assistance is appropriate. It is commonly used to help address symptom clusters that may appear suddenly or intensify over time, and contributes to improved day-to-day comfort during symptomatic periods. This formulation is indicated for the management of redness, swelling, itching, and discomfort of various skin conditions.


Symptom Relief and Application Contexts

The medication is relevant for easing symptoms that become more disruptive during flare-ups, and supports the patient during difficult episodes by easing distress. It is commonly used across conditions characterized by periods of heightened symptoms, including mild presentations of atopic dermatitis (eczema), contact dermatitis, and temporary skin reactions such as from insect bites. HydroSKIN is generally applied in areas where short-term symptom management is appropriate, and is considered relevant for easing symptoms on sensitive anatomical sites, such as the face or eyelids, where low-potency may be appropriate. This supports symptomatic management of localized irritation.

“It is commonly used as part of symptomatic management for mild, localized inflammation where support for symptom control is relevant.”

Quick Fact

Quick Fact: Relief for Inflammation
HydroSKIN plays a role in managing symptoms related to inflammatory or irritative states and contributes to easing the overall symptom load during episodic manifestations.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility and Contraindications for HydroSKIN

Official regulatory documentation defines eligibility for HydroSKIN (topical hydrocortisone) through a set of strict contraindications and population-specific rules.

Category Regulatory Status
Populations for whom use is allowed Adults with corticosteroid-responsive dermatoses.
Populations for whom use is contraindicated Patients with a known hypersensitivity to the ingredients; individuals with active viral skin infections (e.g., herpes, shingles), fungal, or tuberculous infections at the application site.
Conditions where use is prohibited Application to the eyes (not for ophthalmic use), acne, or rosacea.

Age-Related Rules

Use is not recommended for children under 2 years of age in most regulatory contexts. Pediatric patients demonstrate a greater risk of systemic absorption and associated effects, such as HPA axis suppression, due to their larger skin surface area to body weight ratio. Administration in children is generally limited to the least amount necessary.

Special Populations and Restrictions

  • Pregnancy (Category C): Should be used only if the potential benefit justifies the potential risk to the fetus. Extensive or prolonged use is specifically limited.
  • Lactation: Caution should be exercised when administered to a nursing woman, as it is unknown if systemic absorption results in detectable quantities in breast milk.
  • Comorbidities: Caution is required for patients with diabetes or history of Cushing's syndrome, as systemic absorption may worsen these conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

When using HydroSKIN (hydrocortisone topical), the risk of interactions with other medicines, supplements, and products is generally considered low because only a small amount of the active ingredient is absorbed through the skin into the bloodstream. However, it is important to inform your healthcare provider about all medications you are currently taking, including prescription and over-the-counter drugs, vitamins, herbal supplements, and other topical preparations.


Products Requiring Special Caution

Product Category Potential Concern
Other Steroid Products (topical or oral) Concomitant use with other corticosteroids may increase the risk of systemic side effects, particularly if applied over large areas, for prolonged periods, or with occlusive dressings.
Immunizations/Vaccines Topical corticosteroids may potentially reduce the immune response to certain live virus vaccines. Consult your healthcare provider before receiving any vaccinations.
Latex Products HydroSKIN’s inactive ingredients may damage and reduce the effectiveness of latex-containing products such as condoms and diaphragms. Avoid contact with these items.

There is no known direct interaction between the typical use of topical hydrocortisone and alcohol or specific foods.

Always discuss any pre-existing medical conditions, such as diabetes or a known skin infection at the treatment site, with your healthcare provider, as these may affect the use and safety of HydroSKIN.

Mechanism of Action

How HydroSKIN Works


Modulating Inflammation at the Genetic Level

Hydrocortisone's action begins as an agonist of the intracellular Glucocorticoid Receptor ( GR), which then enters the cell nucleus to modulate gene expression. This genomic mechanism works by suppressing the transcription of genes (via transrepression of NF-kappa B) responsible for creating pro-inflammatory proteins, such as cytokines and PLA2. This shift in cellular programming constitutes the primary pathway of anti-inflammatory modulation.


Blocking Local Chemical Mediator Synthesis

The genetic suppression of Phospholipase A2 ( PLA2) functionally blocks the Arachidonic Acid Cascade, thereby halting the synthesis of powerful local mediators like prostaglandins and leukotrienes. The reduction in these vasoactive chemicals and irritants results in key physiological changes: local vasoconstriction and decreased fluid leakage from capillaries. This cascade directly translates to reduced local tissue reactivity and diminished peripheral sensory nerve activation.

Dosage and Administration Information

HydroSKIN is a topical preparation that is intended strictly for external, cutaneous use only and is available as a cream or ointment in approved strengths. The standard administration pattern involves applying a thin film or a small amount of the preparation to the specific affected skin area. The typical dosing frequency for adults and children aged 2 years and older is generally two to four times daily.

Administration Method and Duration

To facilitate proper application, the preparation is gently rubbed in until it disappears from the skin surface, and contact with the eyes is avoided during this process. Use is characterized as short-term and intermittent. Therapy is discontinued when control of the condition is achieved, and treatment duration generally does not exceed four weeks total. If no noticeable improvement is observed after two weeks of consistent use, the clinical situation is typically reassessed.

Age-Specific Rules

Administration for pediatric patients involves specific parameters. For children 2 years of age and older, the duration of treatment is often limited to a maximum of seven to ten days. For infants under 2 years, use is conducted under the advice and supervision of a doctor. Furthermore, occlusive dressings—including covering the area with bandages or using tight-fitting diapers or plastic pants for infants—are avoided unless directed by a healthcare provider, as this practice may increase drug absorption.

Recent Clinical Evidence

HydroSKIN: Overview of Clinical Studies


Evidence for use in Atopic Dermatitis (Eczema)

The research landscape for HydroSKIN includes studies that have primarily explored conditions characterized by fluctuating or episodic manifestations, such as atopic dermatitis (eczema). The evidence was evaluated in numerous Randomized Controlled Trials (RCTs) and subsequent analyses that combine findings, known as systematic reviews and meta-analyses.

Studies tracked changes measured during short-term periods, examining specific symptoms in adults and children with mild-to-moderate disease. Researchers monitored changes in objective scores that measure symptom severity, as well as patient-reported outcomes describing discomfort, particularly relating to redness and pruritus (itching). Findings describe patterns observed when comparing symptom outcomes to those recorded when applying a non-active cream base.

Evidence for General Inflammatory Symptoms

HydroSKIN was also studied for its application in a broader range of localized inflammatory and pruritic skin conditions. The evidence base includes clinical trials that monitored signs linked to inflammatory or irritative states. Studies submitted as part of the regulatory review process often use standardized lab tests, such as vasoconstrictor assays, to help estimate the anti-inflammatory potential being evaluated.

The agent belongs to a class of compounds that was observed in studies examining localized skin inflammation. Its regulatory review included consideration of this class effect, with data describing patterns related to anti-inflammatory activity in trials assessing short-term or episodic symptom patterns.


Research Gaps and Long-Term Data

Research exploring short-term symptom changes focused on acute episodes, with typical study follow-up durations ranging from just a few weeks to about six weeks. Long-term effects, including how consistent the findings are over many months (the durability of the agent's effect), are not fully established by the existing trial base.

There is limited information for long-term outcomes. Research exploring prolonged or preventative use of this low-potency agent is ongoing, but data for extended outcomes are still emerging. Furthermore, comparative evidence is often lacking regarding the subtle differences in effect between the cream and ointment formulations.

Key Studies & References NIH MedlinePlus Drug Information: Hydrocortisone Topical

Frequently Asked Questions (FAQ)

Common questions about HydroSKIN (FAQ)


Q: How quickly does HydroSKIN start to work?

Studies and official information indicate that the active ingredient begins working at a cellular level soon after application to modulate the inflammatory process. Studies have examined changes in symptoms such as redness and itching over short-term periods. The time required to observe a noticeable pattern of symptomatic change can vary.


Q: Can HydroSKIN be used for conditions other than the main listed uses?

Official regulatory documents define eligibility and contraindications. HydroSKIN is intended solely for the relief of inflammatory and itching symptoms of corticosteroid-responsive dermatoses. For example, it is not recommended or is contraindicated for use on active fungal, viral, or tuberculous infections, or on conditions like acne or rosacea.


Q: Does HydroSKIN interact with common over-the-counter pain relievers?

Since only a small amount of the active ingredient is absorbed through the skin, the risk of systemic interaction with oral medicines like pain relievers is generally not documented in specific detail. However, official information advises disclosing all medications, including over-the-counter drugs, to a healthcare provider.


Q: Is it normal to feel a mild stinging sensation when applying HydroSKIN?

Local skin reactions such as burning, itching (pruritus), and irritation are documented in official safety reports as common adverse reactions. A mild stinging sensation may be consistent with the documented common local reactions.


Q: What is the purpose of the inactive ingredients in HydroSKIN?

The inactive ingredients make up the cream or ointment base of the product. According to product components listed in official documents, these ingredients are necessary to help stabilize the medication and facilitate the proper delivery and absorption of the active ingredient into the skin.


Q: Is HydroSKIN available without a prescription?

The availability of HydroSKIN depends on its strength. Official regulatory status confirms that some lower-strength formulations of the active ingredient are classified as over-the-counter (OTC) products, meaning they can be purchased without a prescription, while higher strengths generally require one.


Q: What happens if I stop using HydroSKIN suddenly?

Regulatory documents suggest that if HydroSKIN is used for extended periods or over large body areas, stopping use suddenly may result in infrequent signs of 'steroid withdrawal.' This possibility is related to the potential, though reversible, suppression of the body's natural hormone production (HPA axis suppression).


Q: Are there any specific foods or drinks to avoid while using HydroSKIN?

Official summaries state there is no known direct interaction between the typical use of HydroSKIN and specific foods or drinks, including alcohol. Therefore, no changes to eating and drinking habits are generally documented in official labeling.


Q: Is HydroSKIN known to cause weight gain?

The most common reactions are local. Systemic absorption associated with extensive or prolonged use can, in rare instances, lead to endocrine effects. These effects may include physical signs consistent with Cushing’s syndrome, which can involve weight gain.


Q: Does HydroSKIN have any warnings related to alcohol consumption?

Official regulatory information specifies that there is no known direct interaction between the typical use of topical hydrocortisone and the consumption of alcohol.


Q: Can I use other topical products, like makeup or sunscreens, along with HydroSKIN?

Official patient information states that this medication should only be used for the disorder for which it was intended, and that a healthcare provider should be informed about all other topical preparations being applied. Specific guidance on non-medical products like makeup or sunscreens is not detailed in the official documents.


Q: Is HydroSKIN effective for treating fungal infections?

Official regulatory documents indicate that HydroSKIN is contraindicated, meaning its use is not allowed, when an active fungal infection is present. This is because the action of the corticosteroid may reduce resistance to the infection.


Q: Does HydroSKIN have different effects on different skin tones?

Adverse reactions documented in regulatory documents include hypopigmentation (lightening of the skin), which is reported with a frequency classified as 'not known.' This effect may be more noticeable on darker skin tones.


Q: Is HydroSKIN a new medication, or has it been available for a while?

The active ingredient in HydroSKIN, hydrocortisone, is not a new medication. It has been approved and available in various topical formulations for several decades, dating back to initial regulatory approvals in the mid-1970s.


Q: What is the risk of withdrawal symptoms from HydroSKIN?

Official safety documents indicate the risk of developing symptoms upon discontinuation is more likely following prolonged treatment, application over large areas, or use under an occlusive dressing. This possibility is linked to the potential for HPA axis suppression.


Q: Can HydroSKIN affect blood sugar levels?

Official documents describe the possibility of systemic absorption leading to effects such as hyperglycemia (high blood sugar). Therefore, caution is expressed for use in patients with pre-existing conditions like diabetes.


Q: Is HydroSKIN known to interact with herbal supplements?

While the low systemic absorption suggests a low risk, official patient information consistently advises patients to inform their healthcare provider about all medicines, supplements, and herbal products they are taking.


Q: Can HydroSKIN cause changes in skin pigmentation?

Official adverse event documents confirm that hypopigmentation, or lightening of the skin, has been reported as a possible local skin effect. The frequency of this reaction is officially documented as 'not known.'


Q: Are there any restrictions on donating blood while using HydroSKIN?

Regulations regarding blood donation are set by national health bodies and depend on the specific circumstances of use, such as the area covered and the duration of treatment. Individuals using topical corticosteroids are generally required to disclose this information to the blood service, which will determine eligibility.


Q: Can I share my HydroSKIN prescription with someone else?

Prescription medications are intended exclusively for the patient for whom they were prescribed. General regulatory principles ensure the drug and dosage are specific to the individual’s needs, and sharing is not permitted.


Q: How does the effectiveness of HydroSKIN compare across different age groups?

Official guidance provides specific limits on the duration of use for pediatric patients due to safety considerations. Clinical studies have explored the anti-inflammatory and anti-itch effects of HydroSKIN in both adults and children aged 2 years and older.


Q: Is HydroSKIN considered a strong or mild treatment?

HydroSKIN is officially classified as a low-potency topical corticosteroid. This classification indicates that it is positioned among the milder options available within the class of anti-inflammatory skin treatments.

How should HydroSKIN be stored and disposed of?

The official labeling specifies strict requirements for storing and disposing of HydroSKIN (topical hydrocortisone) to maintain its stability and ensure safety.

Storage Conditions

Item Official Regulatory Statement
Temperature Store at Controlled Room Temperature, 20^circC to 25^circC (68^circF to 77^circF).
Protection Keep from freezing, and away from excess heat, moisture, and direct light.
Packaging Keep the product in the original container with the lid tightly closed.
Child Safety Mandatory instruction: Keep out of the sight and reach of children.

Disposal Requirements

Unused or expired HydroSKIN must be disposed of according to applicable local regulations. Official guidance recommends mixing the medicine with an undesirable substance (such as used coffee grounds or dirt), sealing the mixture in a bag, and disposing of it in the household trash, while avoiding discharge into drains or water courses.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of HydroSKIN found in:

A-Z Index: